COX-2 and Colorectal Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|27|2229-2251

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.27, 2003-10, pp. : 2229-2251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regular aspirin reduces COX-2-positive colorectal cancer risk

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The role of COX-2 in intestinal cancer

By Williams C.S.   Shattuck-Brandt R.L.   DuBois R.N.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 1, 1999-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

The Significance of COX-2 and COX-2 Inhibitors in Liver Fibrosis and Liver Cancer

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 2, 2005-01 ,pp. : 199-206

Bentham Science Publishers

Access to resources Recommend Favorite

Low Dose Aspirin, COX-Inhibition and Chemoprevention of Colorectal Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-06 ,pp. : 493-503

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer and Cyclooxygenase-2 (COX-2) Inhibition

By  

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 627-634

Bentham Science Publishers

Access to resources Recommend Favorite